Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)



Status:Recruiting
Conditions:Brain Cancer, Endocrine
Therapuetic Areas:Endocrinology, Oncology
Healthy:No
Age Range:Any
Updated:2/16/2018
Start Date:October 9, 2012
End Date:October 2023
Contact:Nancy D. Perrier, MD
Phone:713-792-6940

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The study aims to identify predictors of disease in patients with hyperparathyroidism (HPTH)
who undergo surgery.

Researchers aim to identify somatic mutations and inherited genetic variants which may help
predict the development of PNET in patients with hyperparathyroidism.

Inclusion Criteria:

1. MEN1 patients who have undergone parathyroidectomy and did not develop PNET.

2. MEN1 patients who have undergone parathyroidectomy and had surgical removal of PNET.

Exclusion Criteria:
We found this trial at
1
site
University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials